Overview

Post Marketing Survey of Vesicare in Japan

Status:
Completed
Trial end date:
2011-04-01
Target enrollment:
Participant gender:
Summary
This study is to evaluate the effect of Vesicare on quality of life (QOL) in female patients.
Details
Lead Sponsor:
Astellas Pharma Inc
Treatments:
Solifenacin Succinate